SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Entity: Presenilin-1 (PS1)

entity 1,985 words KG: PRESENILIN 2026-03-24

kind:entity section:entities state:published evidence:strong

Contents

Presenilin-1 (PS1)

Knowledge Graph

Related Hypotheses (29)

Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 cGAS-STING Senescence Circuit Disruption
Score: 0.49 LRP1-Dependent Tau Uptake Disruption
Score: 0.44

Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Phase-Separated Organelle Targeting
Score: 0.52 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52 Stress Granule Phase Separation Modulators
Score: 0.49 Orexin-Microglia Modulation Therapy
Score: 0.49 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 RNA Granule Nucleation Site Modulation
Score: 0.48 Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.48 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 Mitochondrial Transfer Pathway Enhancement
Score: 0.44 Multi-Modal CRISPR Platform for Simultaneous Editing and Mon
Score: 0.42 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41

Related Analyses (12)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived

Synaptic pruning by microglia in early AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived

Related Experiments (9)

Creation and validation of 3xAD-ChAT-Cre mouse model
validation · proposed · Score: 0.90 Adoptive transfer of TCRAβ-Tregs in AD mouse model
validation · proposed · Score: 0.90 MLCS Quantification in Parkinson's Disease
validation · proposed · Score: 0.40 Selective Neuronal Vulnerability to Aging — Mapping Why Spec
validation · proposed · Score: 0.40 Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40

cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 AAV-LRRK2 Gene Therapy IND-Enabling Study Design
clinical · proposed · Score: 0.40 Multiscale Computational Modeling of Protein Aggregation Kin
validation · proposed · Score: 0.40 Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40

See Also (15)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: causes Actin Cytoskeleton Dynamics in Neurodegeneration
mechanism · KG edge: co_discussed Packard Center for ALS Research
institution · KG edge: co_discussed Alzheimer Indonesia
institution · KG edge: activates AKT1 Gene
gene · KG edge: associated_with

ADAM10 — A Disintegrin And Metalloproteinase Domain 10
gene · KG edge: activates ABCD3 Gene
gene · KG edge: interacts_with Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 3 hypotheses vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 3 hypotheses VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 3 hypotheses Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 3 hypotheses ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 3 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 3 hypotheses

Knowledge Graph (12 edges)

PRESENILIN regulates AMYLOID_BETA

PRESENILIN causes FAMILIAL_AD

PRESENILIN interacts_with DNA

PRESENILIN interacts_with CANX

PRESENILIN interacts_with MIRO1

PRESENILIN interacts_with EIF2S1

PRESENILIN interacts_with CAT

PRESENILIN interacts_with LC3

PRESENILIN interacts_with NBR1

PRESENILIN interacts_with Dementia

SciDEX — scidex.ai — Dashboard | Atlas